Whitehawk Therapeutics, Inc. (WHWK) › Cash & EquivalentsWhitehawk Therapeutics, Inc. (WHWK) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2007: $02009: $11.1K2010: $26.9K2011: $4.1K2012: $4.6K2013: $6.3K2014: $5.3K2015: $5.14M2016: $1.61M2017: $20.26M2018: $62.61M2019: $38.52M2020: $4.46M2021: $148.99M2022: $39.02M2023: $62.89M2024: $28.67M2025: $37.57M$37.57M2007Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$37.57M+31.0%2024$28.67M-54.4%2023$62.89M+61.2%2022$39.02M-73.8%2021$148.99M+3244.3%2020$4.46M-88.4%2019$38.52M-38.5%2018$62.61M+209.0%2017$20.26M+1158.9%2016$1.61M-68.7%2015$5.14M+97642.9%2014$5.3K-16.2%2013$6.3K+36.4%2012$4.6K+11.7%2011$4.1K-84.7%2010$26.9K+141.4%2009$11.1K—2007$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share